Japan Tissue Engineering Co

Japan Tissue Engineering Co Acquisitions (Net)

The Acquisitions (Net) of Japan Tissue Engineering Co (7774.T) as of Oct 17, 2026 is -138.65 M JPY. In the previous year, Acquisitions (Net) was 30.97 M JPY — a change of -547.70% (lower).

Acquisitions (Net)

-138.65 MJPY

YoY

-547.70%

Last updated:

Acquisitions (Net) of Japan Tissue Engineering Co is 2025 -138.65 M JPY. Acquisitions (Net) of Japan Tissue Engineering Co was 2024 30.97 M JPY. It decreases by -547.70% lower compared to the previous year.

The Japan Tissue Engineering Co Acquisitions (Net) history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Acquisitions (Net)
Date
Acquisitions (Net)
Jan 1, 2018
-397.59 M JPY
Jan 1, 2019
100.61 M JPY
Jan 1, 2020
300.29 M JPY
Jan 1, 2021
200.28 M JPY
Jan 1, 2022
751,000.00 JPY
Jan 1, 2023
1.30 B JPY
Jan 1, 2024
30.97 M JPY
Jan 1, 2025
-138.65 M JPY
The Japan Tissue Engineering Co Acquisitions (Net) history
YEARAcquisitions (Net)YoY
-138.65 MJPY-547.70%
30.97 MJPY-97.62%
1.30 BJPY+173,089.21%
751,000.00JPY-99.63%
200.28 MJPY-33.31%
300.29 MJPY+198.48%
100.61 MJPY-125.30%
-397.59 MJPY-26,623.42%
1.50 MJPY-100.06%
-2.70 BJPY+199.64%
-900.85 MJPY-364.41%
340.70 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Japan Tissue Engineering Co Stock analysis

What does Japan Tissue Engineering Co do? Japan Tissue Engineering Co Ltd, listed on the Tokyo Stock Exchange with ticker 7774.T, operates in the Health Care sector within the Biotechnology industry. The company, headquartered in Gamagori-shi, Japan, employs 215 people. It went public on December 21, 2007. Japan Tissue Engineering develops and manufactures cultured biological cells and tissues, offering regenerative medicine products such as autologous cultured epidermis JACE and autologous cultured cartilage JACK. The firm also provides outsourcing services including CDMO and CRO services, and supports research and development with human cultured tissues. Japan Tissue Engineering Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Japan Tissue Engineering Co stock

Acquisitions (Net) of Japan Tissue Engineering Co is -138.65 M JPY in 2025.

Acquisitions (Net) of Japan Tissue Engineering Co changed from 30.97 M JPY to -138.65 M JPY, representing a -547.70% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Acquisitions (Net) Japan Tissue Engineering Co since 2006 – with annual values, charts, and detailed analysis.

Net acquisitions represent the cash spent on acquiring other businesses, net of divestitures. Large acquisitions can transform a company's growth trajectory.

Acquisitions (Net)'s JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Acquisitions (Net)'s Japan Tissue Engineering Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Japan Tissue Engineering Co

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Japan Tissue Engineering Co